Stock to Watch, Emgold Mining, EMR.V, EGMCF.PK
Stock to Watch!
Emgold Mining Corp. EMR (TSX.V) EGMCF (OTCQB)
Emgold Mining Corporation is a gold exploration and development company with five exploration and development projects in North America. The Company is focused on acquiring and developing quality properties, and advancing them through exploration, permitting, construction, and ultimately create a new gold producing company.
Focus
The Company is focused on reopening the historic Idaho-Maryland Gold Mine located in Grass Valley, California. The Company plans to develop a 2,400 ton per day mining operation with potential to produce over 200,000 ounces of gold per year.
Additional Properties
Emgold Mining also has a portfolio of four early to middle stage mineral exploration projects including the Buckskin-Rawhide Property, and the Koegel Rawhide Property in Nevada, the Stewart Property, and the Rozan Property in British Columbia.
INVESTMENT HIGHLIGHTS
-
Opportunity to invest in a world class gold asset whose main property has potential to develop a 3-5 million ounce gold resource.
-
Idaho-Maryland Project in California has significant gold resources and production potential
-
Measured & Indicated: 472,000 ounces of gold. Inferred: 1,002,000 ounces of gold.
-
Company planning to produce over 200,000 ounces of gold annually.
-
13 million ounces of gold was produced within 3 mile radius, see why Emgold's has been involved with this property since 1993!
-
-
Four additional excellent exploration properties in Nevada and British Columbia. Learn more about these great properties.
-
The Company’s gold assets and solid resource base seems to be currently undervalued with the stock trading at $0.10 per share, implied value per ounce of only $4 per ounce of gold. See the Valuation
-
The Company successfully raised $2.2 million and planning to raise additional funds to advance Idaho-Maryland project.
-
Strong management team and Board of Directors with considerable exploration and development experience. meet the Management Team!
-
Find out the 'Target Price', read the compelling analysis.
-
Full Report is now available for FREE! download now.
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company or a third party. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
DailyStockDeals.com -Stock News- SNPK at inflection point. Today is the Day! See why?
The Meteoric Rise of SNPK
The stock has been going up 10% or more everyday.
The stock could take a big hit if it couldn't pass through
the psychologically very, very critical milestone of One
Billion Dollar!
Two important things to watch:
-
If the stock fails to achieve $1 Billion Market Cap.
-
Fails to cross the critical $2.50 hurdle today.
It might pause right here and/or you may see profit taking.
To our Members and Followers: you heard it here first, make a note to yourself.
Happy trading!
(shale gas news) Ecosphere Technologies, ESPH.OB, Summary, Profile
Ecosphere Technologies | ESPH.OB | Summary | Profile
Ecosphere Technologies, ESPH.OB, is a diversified engineering and technology company, engaged in clean technologies and services.
The company designs and builds mobile water filtration equipment, waste water treatment and provides water recycling services to the energy exploration companies.
Ozonix®
The company's patented Ozonix technology is primarily used by the gas and oil companies for treatment and recycling of water used in fracking. The technology eliminates, bacteria and reduces scaling, eliminating the need to dispose the contaminated water. This process helps Oil&Gas companies save money and improve productivity.
Mobile, High-Volume Fluid Reclamation:
-
Ozonix® Eliminates Liquid Chemical Biocides
-
Provides Rapid On-Site Water Reclamation
-
Oxidizes Contaminates, Killing Bacteria and Destroying Bacteria Cell Walls On-the-Fly
-
Eliminates Costly Biocides and Reduces Scale Inhibitors Needed for Corrosion Control
-
Eliminates the Costs Associated with Waste Separation, Transportation & Disposal
-
High-Volume Water Treatment Capabilities allow for Quick Turnaround Time and Increased Utilization
-
Self-Contained Ozonix® Systems offer Minimal Mobilization and Demobilization Arrangements
-
Environmentally Safe, Eliminating Hazardous Waste Byproducts and Residual Pollutants
-
Ozonix® Preserves Natural Water Resources Minimizing Customers' Carbon Footprints
The Shale Gas industry is expanding at a rapid pace, waste water treatment, recycling and chemicals used in the process of fracking is a major environmental concern. The company's has developed a technology that doesn't require any chemicals. The company has a great technology serving the growing need of Oil & GAS, Mining Industries and Municipalities, and an Excellent management team, Keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
Marina Biotech, MRNA, Summary, Profile
Marina Biotech | MRNA | Summary | Profile
Marina Biotech – MRNA - is focused on the discovery and development of novel RNAi-based therapeutics in the area of oncology, bladder and liver cancer.
The company is exploring the potential of RNAi-based therapeutics through the development of multiple broad-based, state-of-the-art drug discovery platforms built upon industry leading expertise in RNA chemistry, microbiology and oligonucleotide delivery.
Bladder Cancer
Marina Biotech is conducting preclinical studies in bladder cancer utilizing our tauRNAi platform. Bladder cancer ranks as the 4th most common cancer in men, and the 9th leading cause of death in men in the US. Approximately 75% of all bladder cancer cases in the US are in men. In the US, it is currently estimated that on a yearly basis, more than 70,000 new patients will be diagnosed with bladder cancer and approximately 15,000 deaths will occur from bladder cancer.
Liver Cancer
Marina Biotech is utilizing the tauRNAi platform in preclinical studies of hepatocellular carcinoma, more commonly known as liver cancer. Leading causes of liver cancer include viral infection (hepatitis), toxins, and damage to the liver that result in cirrhosis. Worldwide there are more than 500,000 new cases of liver cancer each year. It is currently estimated that in the US, more than 20,000 new cases of liver cancer will be diagnosed and 19,000 deaths are expected to occur due to liver cancer.
The company has partnered with World's leading companies and universities, including University of Michigan and University of Helsinki. The partners include Roche and Novartis.
The stock is trading near 52WK LOWS, may bounce back keep an eye!
Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®
we received or expecting compensation from the featured company. Our firm, principals and staff may own/buy/sell/trade stock/securities of this company. Always Read the full Disclosure/Disclaimer. Thanks.
- Premier Beverage, PBGC, Profile, Summary
- Shengkai Innovations | VALV | Profile | Summary
- FDA's surprise Valentine Gift to WOMEN!
- CHGS, China Geng Sheng Minerals, Profile, Summary
- BNVI, Bionovo, Delivers a Healthy 43% Returns in 5 days!
- Improving women's health and sex life, Bionovo, BNVI
- BPAX shareholders wonder if there is a Gel for stock dysfunction!
Feed Entries
